ProPhase Labs, Inc. Inventory, Raw Materials, Gross
ProPhase Labs, Inc. (PRPH) had Inventory, Raw Materials, Gross of $2.00 thousand as of 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Notes › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-06-01
- 2025-12-31: Inventory, Raw Materials, Gross $2.00K.
- 2024-12-31: Inventory, Raw Materials, Gross $147.00K.
- 2023-12-31: Inventory, Raw Materials, Gross $448.00K; Inventory, Raw Materials, Gross as first filed $1.62M.
- 2022-12-31: Inventory, Raw Materials, Gross $1.64M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2025-12-31 | $2.00K 10-K · filed 2026-06-01 | |
| 2024-12-31 | $147.00K 10-K · filed 2026-06-01 | |
| 2023-12-31 | $448.00K 10-K · filed 2025-04-01 | $1.62M 10-K · filed 2024-03-29 |
| 2022-12-31 | $1.64M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.90M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.72M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.51M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.25M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.30M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.55M 10-K · filed 2022-03-31 | $3.46M 10-K · filed 2021-03-31 |
| 2020-09-30 | $1.51M 10-Q · filed 2020-11-19 | |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $993.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.02M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $960.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.10M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.37M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.23M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.38M 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $1.45M 10-Q/A · filed 2018-08-20 | |
| 2017-12-31 | $1.27M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $1.49M 10-Q/A · filed 2018-08-20 | |
| 2017-06-30 | $1.59M 10-Q/A · filed 2018-08-20 | |
| 2017-03-31 | $1.26M 10-Q/A · filed 2018-08-20 | |
| 2016-12-31 | $1.40M 10-Q/A · filed 2018-08-20 | |
| 2016-09-30 | $1.66M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.53M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.42M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.30M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $1.68M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $931.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $816.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $798.00K 10-K · filed 2016-03-29 | |
| 2013-12-31 | $434.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |